(Q43798401)

26 November 2017

Insulin resistance quantification by fasting insulin plasma values and HOMA index in a non-diabetic population (English)

1 reference

26 November 2017

1 reference

1 reference

Ascaso JF

1

1 reference

26 November 2017

Romero P

2

1 reference

26 November 2017

Real JT

3

1 reference

26 November 2017

Priego A

4

1 reference

26 November 2017

Valdecabres C

5

1 reference

26 November 2017

Carmena R

6

1 reference

26 November 2017

1 November 2001

1 reference

26 November 2017

1 reference

26 November 2017

117

1 reference

26 November 2017

530-533

1 reference

26 November 2017

14

1 reference

Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population.

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2972168-9

Coronary Heart Disease Incidence and Cardiovascular Mortality in Busselton with Reference to Glucose and Insulin Concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2972168-9

Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2972168-9

Glucose tolerance, plasma insulin, HDL cholesterol and obesity: 12-year follow-up and development of coronary heart disease in Edinburgh men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2972168-9

The metabolically obese, normal-weight individual revisited.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2972168-9

A study of insulin resistance using the minimal model in nondiabetic familial combined hyperlipidemic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2972168-9

Determination of Glucose in Blood Using Glucose Oxidase with an Alternative Oxygen Acceptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2972168-9

Quantitative aspects of the reaction between insulin and insulin-binding antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2972168-9

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2972168-9

Insulin sensitivity and its measurement: structural commonalities among the methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2972168-9

Assessment of insulin sensitivity in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2972168-9

Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2972168-9

A prospective analysis of the HOMA model. The Mexico City Diabetes Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2972168-9

Insulin levels during fasting and the glucose tolerance test and Homa's index predict subsequent development of hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2972168-9

Features of the metabolic syndrome predict higher risk of diabetes and impaired glucose tolerance: a prospective study in Mauritius

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2972168-9

10.1016/S0025-7753(01)72168-9

7 January 2021

Identifiers

DOI

1 reference

26 November 2017

1 reference